Director, Drug Product
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
The Director, Drug Product, will lead formulation and process development activities for small-molecule and biologic drug products within the Pharmaceutical Development & Manufacturing (PDM).
The role will oversee development of portfolio programs from candidate assessment, preformulation, and IND-enabling studies through clinical development, registration, technology transfer, process validation, commercialization, and lifecycle management.
Responsibilities include phase-
